Navigation Links
Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
Date:7/10/2008

- Commitment Reflects Eisai's human health care (hhc) Mission to Serve the

Needs of Patients and Families -

WOODCLIFF LAKE, N.J., July 10 /PRNewswire/ -- Eisai Inc., as a member company of the Pharmaceutical Research and Manufacturers of America (PhRMA), today announced that it has renewed its commitment to pursue policies and practices that best serve the needs of patients and the healthcare community in accordance with PhRMA's newly revised Code on Interactions with Healthcare Professionals.

The revised PhRMA Code, effective January 2009, builds upon improvements already made since its adoption and is part of an ongoing industry effort to ensure that pharmaceutical marketing practices comply with the highest ethical standards. The Code was first adopted in 2002 to govern the pharmaceutical industry's relationships with physicians and other healthcare professionals.

Hajime Shimizu, Chairman & CEO, Eisai Corporation of North America and Eisai Inc., and Board Director, PhRMA, stated, "The newly revised PhRMA Code is consistent with Eisai's established Charter of Business Conduct, which is founded on our human health care (hhc) mission to give first thought to patients and their families and to increasing the benefits that health care provides. Eisai strives to uphold the highest ethical and professional standards relevant to interactions with healthcare professionals."

The newly revised Code serves to reaffirm that interactions between company representatives and healthcare professionals remain focused on informing healthcare professionals about products, providing scientific and educational information and supporting medical research and education.

For complete information on PhRMA's Code on Interactions with Healthcare Professionals, please refer to the PhRMA web site at: http://www.phrma.org .

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with fiscal year 2007 (year ended March 31, 2008) sales of approximately $3 billion, including the results of the acquisition of MGI PHARMA, Inc.

Eisai Inc. employs approximately 1,500 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit http://www.eisai.com .


'/>"/>
SOURCE Eisai Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eisai Inc. and the Alzheimers Association Introduce the C.A.R.E. Pharmacy Award and Call for Nominations
2. Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
3. AMERIGROUP Renews Contract with Tennessee
4. WHO Report Says 9.7 Million at Risk of Death from AIDS Today; AHF Renews Call for US Congress to Commit to Scale up Treatment to Seven Million Lives
5. Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract
6. Hall of Fame Shortstop Cal Ripken, Jr. Renews Commitment to Lung Cancer
7. Wiley-Blackwell renews carbon neutral commitment
8. St. Marys Medical Center Renews RCM & Technology With MED3000
9. Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians
10. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
11. ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017   Divoti USA will engrave and ... standard of the latest FDA requirements, which stipulates new criteria regarding ... in need of Medical ID jewelry such as Medical ID Bracelets, ... engraved in terms of the new FDA requirements . ... Divoti offers this dark mark fiber ...
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
Breaking Medicine Technology: